Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rebamipide vs Betamethasone for Oral Aphthous Ulcers
NCT06084624Phase 2Recruiting
- Sponsor
- Cairo University
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rebamipide in Aphthous Stomatitis (2 arms), sponsored by Cairo University. Primary endpoint: Pain intensity associated with oral aphthous ulcers at day 7. Started Jul 2026; status: recruiting.
02
Drugs
rebamipide
03
Conditions
Aphthous Stomatitis
Beyond the preview
Go deeper on NCT06084624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06084624.